Conditions: Dry Eye Syndromes
Keywords: LASIK
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 137
Healthy volunteers: no

Brief summary:
This study will evaluate the safety and efficacy of cyclosporine ophthalmic emulsion administered twice daily following LASIK surgery

Detailed description:

Arms:
arm 1: Cyclosporine Ophthalmic Emulsion 0.05% (RESTASIS®) arm 2: Artificial Tears (REFRESH ENDURA®)

Interventions: intervention 1: Cyclosporine Ophthalmic Emulsion 0.05% (RESTASIS®) intervention 2: Artificial Tears REFRESH ENDURA®
Intervention descriptions: intervention 1: Cyclosporine Ophthalmic Emulsion 0.05% administered twice daily in each eye for 6 months following LASIK surgery intervention 2: REFRESH ENDURA® administered twice daily in each eye for 6 months following LASIK surgery

Protocol document: